Julie Traclet

Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis.

Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis.

Journal: Respiratory medicine and research
Published: December 26, 2025

Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohort.

Risk of hospitalisation and mortality among patients with interstitial lung disease and COVID-19: A French multicentre prospective cohort.

Journal: Pulmonology
Published: December 09, 2025

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

Journal: The European respiratory journal
Published: October 17, 2025

Adult male patients with DKC1 mutations present early-onset pulmonary fibrosis and severe prognosis.

Adult male patients with DKC1 mutations present early-onset pulmonary fibrosis and severe prognosis.

Journal: ERJ open research
Published: March 31, 2025

The phenotypic state of biallelic SERPINA1 Q0 variants in α1-antitrypsin deficiency.

The phenotypic state of biallelic SERPINA1 Q0 variants in α1-antitrypsin deficiency.

Journal: ERJ open research
Published: February 15, 2025

Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients.

Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients.

Journal: Journal of clinical medicine
Published: November 28, 2024

Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study.

Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study.

Journal: ERJ open research
Published: May 17, 2024

Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial.

Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial.

Journal: The European respiratory journal
Published: March 08, 2024

Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension.

Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension.

Journal: ERJ open research
Published: December 08, 2023

Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension.

Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension.

Journal: PloS one
Published: December 01, 2023

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis.

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis.

Journal: Frontiers in medicine
Published: November 20, 2023

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.

Journal: Respiratory research
Published: July 11, 2023
Showing 1-12 of 63

Last Updated: 09/26/2026